BioCentury
ARTICLE | Clinical News

BioSpecifics regulatory update

May 17, 1999 7:00 AM UTC

The FDA advised BSTC that it must submit to the agency within 30 days a plan of corrective action related to Good Manufacturing Practices violations noted in the FDA’s recent inspection of BSTC’s faci...